Therefore, cellular and biochemical blood markers of systemic inflammation, such as the neutrophil to lymphocyte ratio (NLR) (that is, the ratio between the total blood neutrophil count and the total blood lymphocyte count) and the albumin to globulin ratio (AGR) (that is, the ratio between albumin concentration and globulins concentration in blood), have recently emerged as prognostic factors for human cancer development (21, 22). Here, ALB is linked to cancer.